Navigation Links
CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant

- Tyrima Demonstrates Good Safety Profile and Excellent Pharmacokinetic Properties -

RESEARCH TRIANGLE PARK, N.C., March 13, 2007 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today announced top-line results from a Phase I clinical trial of Tyrima(TM), its lead candidate for the treatment of depression and anxiety. In this study, Tyrima was safe and well tolerated. Tyrima is a member of a novel class of drugs known as reversible inhibitors of monoamine oxidase A, or RIMAs.

The single-dose, placebo-controlled trial evaluated Tyrima in 41 subjects with doses escalating from 5 mg to 120 mg over the course of the study. Tyrima was well tolerated with no clinically significant adverse events even at the highest dose of 120 mg. Tyrima achieved high plasma concentrations that increased linearly with dose, and the favorable pharmacokinetic half-life should permit once or twice daily dosing. None of the safety and tolerability issues commonly associated with conventional monoamine oxidase A inhibitors (MAOIs) were seen in this study.

"The triple mechanism of MAOI antidepressants has the potential to provide enhanced efficacy to the 30% of patients who do not respond to current therapies, but use of these drugs has been limited by their propensity to cause serious side effects," said Dr. Atul Pande, chief medical officer of CeNeRx. "It is therefore encouraging that Tyrima, a selective and reversible MAO inhibitor specifically designed to avoid these side effects, demonstrated a promising safety profile in its first clinical trial, even at the highest dose. These results provide a strong foundation for proceeding to multiple dose safety studies."

Tyrima's unique mechanism elevates the levels of three key neurotransmitters (serotonin, norepinephrine and dopamine) that affect mood and anx
'"/>




Page: 1 2 3

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
6. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
7. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
8. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:6/19/2013)... NEW YORK , June 19, 2013 /PRNewswire-iReach/ ... a pioneer of modern hair transplant procedures and ... Restoration, was included in the ,Best Doctors, issue ... year. (Photo:  http://photos.prnewswire.com/prnh/20130619/CG34629 ) ... the Best Doctors issue, and his reputation as ...
(Date:6/19/2013)... 2013 Eli Lilly and Company (NYSE: ... illegal scams, purportedly using the name of the company ... targeting the public through postal mail solicitations and job-seekers ... to any foreign lottery organizations and do not conduct ... victims of the scam. The activities described in these ...
(Date:6/19/2013)... 2013 Ellen MacArthur Foundation ... tre åren kommer att vara en partner för ... ekonomi. Efter stiftelsens framgångsrika partnerskap med ... kommer Philips att ansluta sig som partner för ... sin egen verksamhet och stödja stiftelsens arbete inom ...
Breaking Medicine Technology:Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3
... ATLANTA, June 7, 2011 CardioMEMS, Inc ., an ... a proprietary wireless sensing and communication technology for the human ... Yadav, M.D. , is a finalist for the 25th annual ... Entrepreneur category. The awards are sponsored by the Metro Atlanta ...
... June 7, 2011 The ALS Therapy Development Institute ... Michael Capuano (D-MA) with its first ever "Lou Gehrig ... gala event this November 3rd.  The award recognizes ... advocate for additional funding for research leading to an ...
Cached Medicine Technology:Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 2Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 3U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS TDI During Gala Event this November 2
(Date:6/19/2013)... Kleritec, Inc. announced the addition of educational based ... In the recent expansion Kleritec now offers ... pre-school and day care providers. The company envisions the ... across the United States the ability to keep their ... the art and activities packages is all the necessary ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Today, Zane ... Health Insurance Exchange . Zane Benefits, which provides comprehensive ... is the leader in defined contribution and ... Zane Benefits’ website, as part of the Affordable Care ... businesses will become available through new state health insurance ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 As ... cancer continue to mount in courts throughout the U.S., ... Drug Administration (FDA) recently held a meeting to discuss ... as incretin mimetics. According to a June 12th ... from the makers of Januvia and similar drugs, following ...
(Date:6/19/2013)... in emergency medicine and trauma surgery have had ... the days immediately after major injuries, including burns. ... their injuries now are at greatest risk from ... known as sepsis or from inflammation-induced multiorgan ... General Hospital (MGH) investigators that measures the movement ...
(Date:6/19/2013)... June 19 online edition of the journal Nature ... University of California, San Diego School of Medicine visually ... cardiac regeneration occurs in zebrafish after cardiac ventricular injury. ... in the heart are more plastic, or capable of ... More importantly, the research reveals a novel potential source ...
Breaking Medicine News(10 mins):Health News:Kleritec Announces Addition of Educational Products. 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2
... published today in the journal Scientific Reports , a ... Skaggs School of Pharmacy and Pharmaceutical Sciences report that inhibiting ... fuel measurably slows disease progression in a mouse model of ... from damage to the myelin sheath, a protective layer surrounding ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... rise among teens and young people, a new government report ... hospitalized for stroke jumped by more than third between 1995 ... Control and Prevention. The increase may be due partly to ...
... GALVESTON Researchers have found that a protein variation ... consistently present in the brains of people with Alzheimer,s. ... shown that this protein, known as ubiquilin-1, performs a ... precursor protein, a molecule whose malformation has been directly ...
... you always get popcorn at the movies? Or snack while ... USC researchers reveals why bad eating habits persist even when ... reveals the surprisingly simple ways we can counter our habits ... ingenious experiment, researchers gave people about to enter a movie ...
... Teacher, pilot, nurse or engineer? Sex hormones strongly ... occupations they choose, according to psychologists. , "Our ... interest in occupations characterized by working with things ... in psychology, working with Sheri A. Berenbaum, professor ...
... 11.3 days, or $2,280 in lost productivity every year, according to ... Sleep . As a nation, the total cost is 252.7 days ... insomnia has on the average person,s life," said lead author Ronald ... work because of insomnia. They are still going to their jobs ...
Cached Medicine News:Health News:Starving inflammatory immune cells slows damage caused by multiple sclerosis 2Health News:Strokes Rising Among Teens, Young Adults: CDC 2Health News:Strokes Rising Among Teens, Young Adults: CDC 3Health News:Alzheimer's brains found to have lower levels of key protein 2Health News:Habit makes bad food too easy to swallow 2Health News:Sex hormones impact career choices 2Health News:Insomnia costing US workforce $63.2 billion a year in lost productivity, study shows 2
... The C.Ti.2 Hockey is a lightweight, low ... the unique requirements of hockey,players. Tested by ... new, streamlined frame shape that is optimized,for ... Plus, the upper and lower lateral arms ...
... Adjustable Patella Donut is a neoprene ... core and polyester Lycra Fabric that ... full-circumference donut provides for patellar control. ... based allergies or irritations. Click here ...
The Deluxe Knee Immobilizer provides superb lightweight immobilization following injury or surgery. It is available in a wide array of sizes for excellent comfort and fit....
... total knees, meniscus repairs, regenerative chondroplasty, ligament ... gives easy-to-use range of motion control and ... TROM can be used as a rehab ... separately be used with the TROM post-op ...
Medicine Products: